Clinical Validation of Omron WheezeScan

NCT04144699 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2021-09-17

No results posted yet for this study

Summary

The WheezeScan sensitivity and specificity are set to statistically prove equal to or higher values than the predicate PulmoTrack device model 2020.

Conditions

  • Asthma in Children
  • Bronchitis
  • Bronchiolitis

Sponsors & Collaborators

  • University of Wisconsin, Madison

    collaborator OTHER
  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER
  • University of Chicago

    collaborator OTHER
  • Omron Healthcare Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
3 Months
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-11-30
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04144699 on ClinicalTrials.gov